Catford woman reaches remission after groundbreaking myeloma treatment
A 47-year-old Catford woman with incurable myeloma, diagnosed in 2017, has reached remission for the first time in nearly a decade after starting the newly approved drug elranatamab in February 2025, following years of chemotherapy. Doctors at King's College Hospital NHS Foundation Trust praised the treatment’s impact, giving her renewed hope and allowing her to regain activities she loves.